Top

Reviews in Endocrine and Metabolic Disorders

Published in:

01-03-2009

Expression of the IGF and the aromatase/estrogen receptor systems in human adrenal tissues from early infancy to late puberty: Implications for the development of adrenarche

Authors: Alicia Belgorosky, María Sonia Baquedano, Gabriela Guercio, Marco A. Rivarola

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 1/2009

Abstract

Adrenarche is a process of postnatal sexual maturation occurring in higher primates, in which there is an increase in the secretion of adrenal androgens. It is the consequence of a process of postnatal organogenesis characterized by the development of a new zone in the adrenal cortex, the zona reticularis (ZR). The mechanism of this phenomenon remains poorly understood, suggesting that it might be a multifactorial event. A relationship between circulating IGF-I, insulin sensitivity, and adrenal androgens has been postulated. Boys and girls have different patterns of changes in insulin sensitivity at puberty, perhaps secondary to differences in the estrogen milieu. Estrogen effects may also play a role in premature adrenarche. Peripheral or local IGF-1 actions could regulate adrenal progenitor cell proliferation and migration. Since adrenal progenitor cells as well as IGF-I and the IGF-R1 are located in the outer zone of the adrenal cortex during childhood and adolescence, this peripheral cell layer, below the capsule, may contain undifferentiated progenitor cells. Therefore, the IGF-R1 signaling pathway might positively modulate the proliferation and migration of adrenal progenitor cell to stimulate the development of adrenal zones, including ZR. However, no evidence of a direct action of IGF-I on ZR was found. In addition, a role for estrogens in the ontogenesis of ZR is suggested by the presence of aromatase (CYP19) in the subcapsular zona glomerulosa and in the adrenal medulla. Estrogens produced locally could act on ZR by interacting with estrogen receptor beta (ERβ), but not alpha, and membrane estrogen receptor GPR-30. An estradiol-induced increase in DHEA/cortisol ratio was indeed seen in cultures of adrenocortical cells from post-adrenarche adrenals. In summary, several lines of evidence point to the action of multiple factors, such as local adrenal maturational changes and peripheral metabolic signals, on postnatal human adrenal gland ZR formation.

Parker LN. Adrenarche. Endocrinol Metab Clin North Am 1991;20:71–8.PubMed

Zhang L, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and for the polycystic ovary syndrome. Proc Natl Acad Sci U S A. 1995;92:10619–23. doi:10.1073/pnas.92.23.10619.PubMedCrossRef

Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI, et al. Adrenarche results from development of a 3β-hydroxysteroid dehydrogenase-deficient adrenal reticularis. J Clin Endocrinol Metab. 1998;83:3695–701. doi:10.1210/jc.83.10.3695.PubMedCrossRef

Dardis A, Saraco N, Rivarola MA, Belgorosky A. Decrease in the expression of the 3β-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty. Implications to the mechanism of adrenarche. Pediatr Res. 1999;45:384–8. doi:10.1203/00006450-199903000-00016.PubMedCrossRef

Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev. 1997;18:378–403. doi:10.1210/er.18.3.378.PubMedCrossRef

McNutt NS, Jones AL. Observations on the ultrastructure of cytodifferentiation in the human fetal adrenal cortex. Lab Invest. 1970;22:513–27.PubMed

Wolkersdorfer G, Bornstein SR. Tissue remodeling in the adrenal gland. Biochem Pharmacol. 1998;56:163–71. doi:10.1016/S0006-2952(98)00067-7.PubMedCrossRef

Mesiano S, Coulter CL, Jaffe RB. Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17α-hydroxylase/17,20-lyase, and 3β-hydroxysteroid dehydrogenase A isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab. 1993;77:1184–9. doi:10.1210/jc.77.5.1184.PubMedCrossRef

Morley SD, Viard I, Chung BC, Ikeda Y, Parker KL, Mullins JJ. Variegated expression of a mouse steroid 21-hydroxylase/β-galactosidase transgene suggests centripetal migration of adrenocortical cells. Mol Endocrinol. 1996;10(5):585–98. doi:10.1210/me.10.5.585.PubMedCrossRef

10.

Chamoux E, Narcy A, Lehoux JG, Gallo-Payet N. Fibronectin, Laminin, and collagen IV as modulators of cell behavior during adrenal gland development in the human fetus. J Clin Endocrinol Metab. 2002;87:1819–28. doi:10.1210/jc.87.4.1819.PubMedCrossRef

11.

Miller WL. The molecular basis of premature adrenarche: a hypothesis. Acta Paediatr Suppl. 1999;433:60–6. doi:10.1111/j.1651-2227.1999.tb14405.x.CrossRef

12.

Ibáñez L, Potau N, Francois I, De Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab. 1998;83:3558–62. doi:10.1210/jc.83.10.3558.PubMedCrossRef

13.

Ibáñez L, Potau N, Marcos MV, Francois I, De Zegher F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab. 1999;84:4739–41. doi:10.1210/jc.84.12.4739.PubMedCrossRef

14.

Nestler JE, Beer NA, Jakubowicz DJ, Beer RM. Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. J Clin Endocrinol Metab. 1994;78:549–54. doi:10.1210/jc.78.3.549.PubMedCrossRef

15.

Coleman KM, Smith CL. Intracellular signaling patways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci. 2001;6:D1379–91. doi:10.2741/Coleman.PubMedCrossRef

16.

Levin ER. Cellular functions of plasma membrane estrogen receptor. Steroids. 2002;67:471–5. doi:10.1016/S0039-128X(01)00179-9.PubMedCrossRef

17.

Hirst JJ, West NB, Brenner RM, Novy MJ. Steroid hormone receptors in the adrenal glands of fetal and adult rhesus monkeys. J Clin Endocrinol Metab. 1992;75:308–14. doi:10.1210/jc.75.1.308.PubMedCrossRef

18.

Takeyama J, Susuki T, Inoue S, Kaneko C, Nagura H, Harada N, et al. Expression and cellular localization of estrogen eceptors α and β in the human fetus. J Clin Endocrinol Metab. 2001;86:2258–62. doi:10.1210/jc.86.5.2258.PubMedCrossRef

19.

Han VKM, D’ Ercole AJ, Lund PK. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science. 1987;236:193–7. doi:10.1126/science.3563497.PubMedCrossRef

20.

Han VKM, Lund PK, Lee DC, D’ Ercole AJ. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization, and tissue distribution. J Clin Endocrinol Metab. 1988;66:422–9.PubMed

21.

Mesiano S, Jaffe RB. Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids. 1997;62:62–72. doi:10.1016/S0039-128X(96)00161-4.PubMedCrossRef

22.

Guercio G, Rivarola MA, Chaler E, Maceiras M, Belgorosky A. Relationship between the growth hormone/insulin-like growth factor-1 axis, insulin sensitivity and adrenal androgens in normal prepubertal and pubertal boys. J Clin Endocrinol Metab. 2002;87:1162–9. doi:10.1210/jc.87.3.1162.PubMedCrossRef

23.

Guercio G, Rivarola MA, Chaler E, Maceiras M, Belgorosky A. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab. 2003;88:1389–93. doi:10.1210/jc.2002-020979.PubMedCrossRef

24.

Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800. doi:10.1210/er.18.6.774.PubMedCrossRef

25.

Potau N, Ibáñez L, Riqué S, Sanchez-Ufarte C, De Zegher F. Pronounced adrenarche and precocious pubarche in boys. Horm Res. 1999;51:238–41. doi:10.1159/000023377.PubMedCrossRef

26.

Hoffman RP, Vicini P, Sivitz WI, Cobelli C. Pubertal adolescent male–female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal mode. Pediatr Res. 2000;48:384–8. doi:10.1203/00006450-200009000-00022.PubMedCrossRef

27.

Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab. 1995;80:172–8. doi:10.1210/jc.80.1.172.PubMedCrossRef

28.

Singh AB, Hsia S, Alaupovic P, Sinha-Hikim I, Woodhouse L, Buchanan TA, et al. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab. 2002;87:136–43. doi:10.1210/jc.87.1.136.PubMedCrossRef

29.

Lind T. Metabolic changes in pregnancy relevant to diabetes mellitus. Postgrad Med. 1979;55:353–7.CrossRef

30.

Hollingsworth DR. Alterations of maternal metabolism in normal and diabetic pregnancies: difference in insulin-dependent, non insulin-dependent and gestational diabetes. Am J Obstet Gynecol. 1983;146:417–29.PubMed

31.

Oerter Klein K, Baron J, Colli MJ, McDonnell DP, Cutler Jr GB. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest. 1994;94:2475–80. doi:10.1172/JCI117616.CrossRef

32.

Paris F, Servant N, Térouanne B, Balaguer P, Nicolas JC, Sultan CH. A new recombinant cell bioassay for ultrasensitive determination of serum estrogenic bioactivity in children. J Clin Endocrinol Metab. 2002;87:791–7. doi:10.1210/jc.87.2.791.PubMedCrossRef

33.

Belgorosky A, Rivarola MA. Progressive increase in non-sex hormone-binding globulin-bound testosterone and estradiol from infancy to late prepuberty in girls. J Clin Endocrinol Metab. 1988;67:234–7.PubMedCrossRef

34.

Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor γ2. Endocrinology. 2000;141:649–56. doi:10.1210/en.141.2.649.PubMedCrossRef

35.

Denburg MR, Silfen ME, Manibo AM, Chin D, Levine LS, Ferin M, et al. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. J Clin Endocrinol Metab. 2002;87:5604–9. doi:10.1210/jc.2002-020896.PubMedCrossRef

36.

Vuguin P, Linder B, Rosenfeld FG, Saenger P, DiMartino-Nardi J. The roles of insulin sensitivity, insulin-like growth factor I, and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. J Clin Endocrinol Metab. 1999;84:2037–42. doi:10.1210/jc.84.6.2037.PubMedCrossRef

37.

Silfen ME, Manibo AM, Ferin M, McMahon DJ, Levine LS, Oberfield SE. Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity. J Clin Endocrinol Metab. 2002;87:398–403. doi:10.1210/jc.87.1.398.PubMedCrossRef

38.

Brüning JC, Dautam D, Burks DJ, Gillette J, Schubert M, Orban PC, et al. Role of brain insulin receptor in control of body weight and reproduction. Science. 2000;289:2122–5. doi:10.1126/science.289.5487.2122.PubMedCrossRef

39.

Baquedano MS, Berensztein E, Saraco N, Dorn GV, de Davila MT, Rivarola MA, et al. Expression of the IGF system in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche. Pediatr Res. 2005;58:451–8. doi:10.1203/01.PDR.0000179392.59060.93.PubMedCrossRef

40.

Belgorosky A, Baquedano MS, Guercio G, Rivarola MA. Premature Adrenarche: Harbingers and Consequences. In: Pescovitz OH, Walvoord EM, editors. When puberty is precocious. Totowa, NJ: Humana; 2007. p. 217–45.CrossRef

41.

Fottner C, Engelhardt D, Weber MM. Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins. J Endocrinol. 1998;158:409–17. doi:10.1677/joe.0.1580409.PubMedCrossRef

42.

Kristiansen SB, Endoh Acasson PR, Buster JE, Hornsby PJ. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids. 1997;62:258–65. doi:10.1016/S0039-128X(96)00223-1.PubMedCrossRef

43.

L’ Allemand D, Penhoat A, Lebrethon MC, Ardèvol R, Baehr V, Oelkers W, et al. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J Clin Endocrinol Metab. 1996;81:3892–7. doi:10.1210/jc.81.11.3892.CrossRef

44.

Baquedano MS, Saraco N, Berensztein E, Pepe C, Bianchini M, Levy E, et al. Identification and developmental changes of aromatase and estrogen receptor expression in prepubertal and pubertal human adrenal tissues. J Clin Endocrinol Metab. 2007;92:2215–22. doi:10.1210/jc.2006-2329.PubMedCrossRef

45.

Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal Interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. 1998;19:101–43. doi:10.1210/er.19.2.101.PubMedCrossRef

46.

Lloyd T, Weisz J. Direct inhibition of tyrosine hydroxylase activity by catechol estrogens. J Biol Chem. 1978;253:4841–3.PubMed

47.

Yanagihara N, Liu M, Toyohira Y, Tsutsui M, Ueno S, Shinohara Y, et al. Stimulation of catecholamine synthesis through unique estrogen receptors in the bovine adrenomedullary plasma membrane by 17ß-estradiol. Biochem Biophys Res Commun. 2006;339:548–53. doi:10.1016/j.bbrc.2005.11.047.PubMedCrossRef

48.

Conley AJ, Corbin CJ, Hinshelwood MM, Liu Z, Simpson ER, Ford JJ, et al. Functional aromatase expression in porcine adrenal gland and testis. Biol Reprod. 1996;54:497–505. doi:10.1095/biolreprod54.2.497.PubMedCrossRef

49.

Coleman KM, Smith CL. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci. 2001;6:D1379–91. doi:10.2741/Coleman.PubMedCrossRef

50.

Levin ER. Cellular functions of plasma membrane estrogen receptor. Steroids. 2002;67:471–5. doi:10.1016/S0039-128X(01)00179-9.PubMedCrossRef

51.

Filardo E, Thomas P. GPR30: a seven-trasmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab. 2005;16:362–7. doi:10.1016/j.tem.2005.08.005.PubMedCrossRef

52.

Diaz-Perez MJ, Zannis-Hadjopoulos M, Price GB, Wainer IW. Receptor independent effects on DNA replication by steroids. J Cell Biochem. 1998;70:323–9. doi:10.1002/(SICI)1097-4644(19980901)70:3≤323::AID-JCB5≥3.0.CO;2-P.PubMedCrossRef

53.

Singh M, Setalo G Jr, Guan X, Frail DE, Toran-Allerand CD. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-α knock-out mice. J Neurosci. 2000;20:1694–700.PubMed

54.

Montanaro D, Maggiolini M, Recchia AG, Sirianni R, Aquila S, Barzon L. Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation. J Mol Endocrinol. 2005;35:245–56. doi:10.1677/jme.1.01806.PubMedCrossRef

55.

Cardona-Gomez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM. Interactions of estrogen and insulin-like growth factor I in the brain: molecular mechanisms and functional implications. J Steroid Biochem Mol Biol. 2002;83:211–7. doi:10.1016/S0960-0760(02)00261-3.PubMedCrossRef

56.

Hamelers IH, Steenbergh PH. Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr Relat Cancer. 2003;10:331–45. doi:10.1677/erc.0.0100331.PubMedCrossRef

57.

Karl M, Potier M, Schulman IH, Rivera A, Werner H, Fornoni A. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type2 diabetic mesangial cells. Endocrinology. 2005;146:889–900. doi:10.1210/en.2004-1121.PubMedCrossRef

58.

Watanabe M, Nakajin S. Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R. J Endocrinol. 2004;180:125–33. doi:10.1677/joe.0.1800125.PubMedCrossRef

59.

Watanabe T, Yasuda T, Noda H, Wada K, Kasukawa I, Someya T. Estrogen secreting adrenal adenocarcinoma in an 18-month-old boy: aromatase activity, protein expression, mRNA and utilization of gonadal type promoter. Endocr J. 2000;47:723–30.PubMedCrossRef

60.

Young J, Bulun SE, Agarwal V, Couzinet B, Mendelson CR, Simpson ER. Aromatase expression in a feminizing adrenocortical tumor. J Clin Endocrinol Metab. 1996;81:3173–6. doi:10.1210/jc.81.9.3173.PubMedCrossRef

Title: Expression of the IGF and the aromatase/estrogen receptor systems in human adrenal tissues from early infancy to late puberty: Implications for the development of adrenarche
Authors: Alicia Belgorosky
María Sonia Baquedano
Gabriela Guercio
Marco A. Rivarola
Publication date: 01-03-2009
Publisher: Springer US
Published in: Reviews in Endocrine and Metabolic Disorders / Issue 1/2009
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-008-9105-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

Nonhuman primates as models for human adrenal androgen production: Function and dysfunction

Androgen synthesis in adrenarche

Nonclassic adrenal hyperplasia

The adrenal cortex and sexual differentiation during early human development

Clinical spectrum of premature pubarche: Links to metabolic syndrome and ovarian hyperandrogenism

Non-traditional metabolic pathways of adrenal steroids

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage